Genprex Inc. Stock News

COVID vaccine INO-4800 is just one piece of the Inovio (INO) puzzle. Addressing the Human Papilloma Virus remains a high priority for Inovio.

"We will be embarking, probably in September, on very large pivotal studies, and so those are going to be the important ones," a company executive said.

Genprex's CEO will Present at the Proactive Investor Forum on August 4 at 1:40 p.m. ET

Sales of Merck's blockbuster cancer drug Keytruda helped offset an 8% decline in revenue to $10.87 billion during second quarter from $11.76 billion from a year earlier.

Genprex appears live on the Big Biz Show for a second time

The U.S. says it has closed its consulate in Chengdu, China. China ordered the consulate closed in retaliation for a U.S. order to shut down the Chinese...

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today

U.S. officials say the Houston consulate has long been used by China's government to steal medical research and attempt to infiltrate the oil industry.

Orexia has exclusively licensed a small molecule Orexin OX2R agonist program from X-Chem's DNA-encoded libraries

The next day you woke up to the harsh reality of an oatmeal breakfast and dreading learning multiplication tables your older sibling was stressing about. Two names I've talked about, one recently, an

Genprex's collaborators at the University of Pittsburgh receive $2.5 million grant from the NIH to fund diabetes gene therapy study.

Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneer

Astex Pharmaceuticals, Inc.; Taiho Oncology, Inc.; and Otsuka Pharmaceutical Co., Ltd. today announce that the U.S. Food and Drug Administration (FDA)

The researchers found that participants with the greatest total sedentary time had a 52 per cent increased risk of dying from cancer compared with those who had the least sedentary time.

Toronto-based Perimeter Medical Imaging wants to make breast conservation surgeries more efficient by combining an optical coherence tomography device with an AI engine to reduce the number of repeat